Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
1 May 2014

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014

Targeted Anti-cancer Therapies (TAT) conference roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Targeted Anti-cancer Therapies (TAT) conference roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Apr 2014

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )
16 Apr 2014

Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy

Prof Mitch Dowsett - The Institute of Cancer Research, London, UK
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy ( Prof Mitch Dowsett - The Institute of Cancer Research, London, UK )
1 Apr 2014

EBCC 2014 key messages to doctors

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014

Sharing Indian perspectives on CRPC

Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India
Sharing Indian perspectives on CRPC ( Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India )
21 Mar 2014

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie
Insights into mCRPC in China, Thailand and Indonesia - expert discussion ( Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie )
21 Mar 2014